Ruifang Li-Gao, PhD (she/her/hers)

postdoc
Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands
Leiden, Zuid-Holland, Netherlands

Dr. Ruifang Li-Gao has expertise in applying multi-omics approaches to disentangle cardiometabolic disease risks. Currently she is coordinating the omics research in the Netherlands Epidemiology of Obesity (NEO) study in the Netherlands. One of her research focuses is to apply novel multi-omics approaches, such as glycomics, to understand novel risk factors for venous thrombosis.

Presentation(s):

• OC 17.1 - The association between venous thrombosis-associated genetic variants and coagulation factor levels and thrombin generation potential

  Sunday, June 25, 2023
  10:45 – 11:00 ET

• PB0030 - The association between depressive symptom profiles and hemostasis: the biobehavioral pathway to cardiovascular diseases?

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• OC 57.3 - Genome-wide identification of loci controlling plasma coagulation factor IX activity

  Tuesday, June 27, 2023
  11:15 – 11:30 ET

• OC 68.5 - Plasma N-glycan signatures are associated with a first event of venous thromboembolism

  Tuesday, June 27, 2023
  15:45 – 16:00 ET

• PB1410 - The association between microvascular health and coagulation parameters: the Netherlands Epidemiology of Obesity Study

  Tuesday, June 27, 2023
  18:30 – 19:30 ET